Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 5 studies | 32% ± 18% | |
| fibroblast | 3 studies | 23% ± 5% | |
| monocyte | 3 studies | 29% ± 10% | |
| endothelial cell | 3 studies | 28% ± 16% | |
| myeloid cell | 3 studies | 24% ± 6% | |
| endothelial cell of vascular tree | 3 studies | 29% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 80% | 2052.24 | 367 / 459 | 79% | 21.39 | 880 / 1118 |
| skin | 75% | 5648.93 | 1348 / 1809 | 83% | 21.39 | 393 / 472 |
| brain | 59% | 1718.76 | 1557 / 2642 | 84% | 20.23 | 592 / 705 |
| prostate | 48% | 614.42 | 118 / 245 | 79% | 17.52 | 397 / 502 |
| thymus | 45% | 1276.40 | 292 / 653 | 70% | 11.52 | 426 / 605 |
| lung | 51% | 910.40 | 297 / 578 | 61% | 6.31 | 707 / 1155 |
| ovary | 60% | 1858.29 | 108 / 180 | 48% | 5.57 | 205 / 430 |
| esophagus | 30% | 556.88 | 436 / 1445 | 77% | 12.61 | 140 / 183 |
| adrenal gland | 48% | 1219.00 | 123 / 258 | 57% | 12.08 | 132 / 230 |
| stomach | 37% | 959.47 | 132 / 359 | 59% | 6.48 | 169 / 286 |
| pancreas | 7% | 79.28 | 24 / 328 | 84% | 13.12 | 150 / 178 |
| intestine | 32% | 603.35 | 311 / 966 | 58% | 6.46 | 307 / 527 |
| blood vessel | 83% | 2352.11 | 1109 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 8.63 | 24 / 29 |
| bladder | 29% | 578.52 | 6 / 21 | 48% | 4.91 | 242 / 504 |
| adipose | 75% | 2893.40 | 899 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 21% | 394.75 | 36 / 170 | 48% | 5.89 | 219 / 459 |
| kidney | 22% | 338.28 | 20 / 89 | 45% | 5.97 | 402 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 58% | 8.02 | 26 / 45 |
| heart | 49% | 1221.33 | 424 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 28% | 790.93 | 257 / 929 | 0% | 0 | 0 / 0 |
| spleen | 26% | 250.07 | 62 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.72 | 7 / 80 |
| muscle | 7% | 80.05 | 60 / 803 | 0% | 0 | 0 / 0 |
| liver | 2% | 15.46 | 4 / 226 | 5% | 0.38 | 21 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
| GO_0045586 | Biological process | regulation of gamma-delta T cell differentiation |
| GO_0007274 | Biological process | neuromuscular synaptic transmission |
| GO_0007623 | Biological process | circadian rhythm |
| GO_0035767 | Biological process | endothelial cell chemotaxis |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
| GO_0007422 | Biological process | peripheral nervous system development |
| GO_0007517 | Biological process | muscle organ development |
| GO_0033089 | Biological process | positive regulation of T cell differentiation in thymus |
| GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
| GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0045202 | Cellular component | synapse |
| GO_0000785 | Cellular component | chromatin |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | EGR3 |
| Protein name | Early growth response protein 3 (EGR-3) (Zinc finger protein pilot) Early growth response 3 |
| Synonyms | PILOT |
| Description | FUNCTION: Probable transcription factor involved in muscle spindle development. |
| Accessions | E5RIM5 ENST00000317216.3 [Q06889-1] ENST00000522910.1 [Q06889-2] ENST00000519492.1 Q06889 |
